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Concise report
CD3 immunohistochemistry is helpful in the
diagnosis of giant cell arteritis
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Carlo Salvarani2,* and Aroldo Rizzo3,*
Abstract
Objective. To evaluate whether CD3 staining performed routinely on temporal artery biopsy specimens might improve
the sensitivity of temporal artery biopsy in patients with biopsy-negative GCA.
Methods. Two hundred and seventy biopsies were considered for this study, stained with haematoxylin and eosin and
with an anti-CD3 antibody.
Results. The addition of CD3 staining modified the sensibility and the specificity of the histologic examination in 89.47
and 95.00%, respectively, with a positive and negative predictive values of 97.00 and 79.78% .
Conclusion. The addition of CD3 immunostaining to the classic histologic evaluation is accompanied by a significant
increase in the sensibility with a comparable specificity.
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Rheumatology key messages
. CD3 immunohistochemistry may be useful in histological-negative arteries of patients with suspected GCA.
. The addition of CD3 staining significantly increased sensibility and specificity of classic histologic examination.
Introduction
GCA is a large- and medium-sized arteries systemic vas-
culitis [1] resulting in a wide variety of systemic, neurologic
and ophthalmologic complications. GCA is histopatho-
logically characterized by transmural inflammation of the
all the layers of affected arteries by monocyte-derived
macrophages, activated T cells and multinucleated giant
cells. In particular, a massive infiltration by Th1, Th9 and
Th17 CD3+ effector T cells is observed in temporal artery
biopsy (TAB) specimens obtained from patients affected
by GCA with positive biopsy [2, 3]. GCA is diagnosed by
combining symptoms, clinical findings, laboratory results
and diagnostic imaging. The gold standard for the diag-
nosis of GCA is the demonstration of artery wall inflam-
mation on TAB [1]. Frequently, TAB results in false-
negative biopsies in a relevant number of patients, leading
to a significant delay in treatment and possible irreversible
complications [4]. The need to improve the diagnosis of
GCA requires the developement of new staining tech-
niques of TAB specimens. Due to the important role of
CD3+ T cells in the pathogenesis of the disease we
aimed to investigate whether CD3 staining performed rou-
tinely on TAB specimens may improve the sensitivity of
TAB in patients with biopsy-negative GCA.
Methods
Patients and immunohistochemistry
For this study, we retrospectively evaluated all the biop-
sies performed in our centres from January 2003 to June
2016 in patients with suspected GCA. Two hundred and
seventy biopsies obtained from as many patients were
considered. At the time of diagnosis, 28 patients had
vision loss and PMR was associated in 45 patients. At
the time of artery biopsy all the patients were treatment-
naı̈ve or had received glucocorticoids for 41 week. Prior
or current diagnosis of cancer, autoimmune disease other
than GCA or chronic infection was carefully excluded. All
the paraffin-embedded TAB specimens were retrieved,
the tissue cut into 4-mm sections (810 per patient)
and stained with haematoxylin and eosin (H&E).
Immunohistochemical analysis for CD3 was also
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performed on 5-mm-thick paraffin-embedded sections
from artery biopsies and from tonsils (used as positive
controls) as previously described [5]. Briefly, following re-
hydration, antigen was unmasked for 45 min at 95C using
Dako Target retrieval solution (pH 6; Dako, Carpinteria,
CA, USA). Endogenous peroxidase was blocked for
10 min with Dako peroxidase blocking reagent, and non-
specific binding was blocked for 20 min with Dako protein
block. The primary antibodies mouse monoclonal anti-
human CD3 (ab5690, AbCam, Cambridge, UK) was
added and incubated for 1 h at room temperature. An
isotype-matched irrelevant antibody was used as a nega-
tive control. Following three washes with Tris-buffered
saline, slides were incubated for 30 min with peroxidase-
conjugated Dako EnVision polymer. After three further
washings, peroxidase activity was visualized using di-ami-
nobenzidine chromogen (Dako, Carpinteria, CA, USA )
and slides were lightly counterstained with haematoxylin
before dehydration and mounting in DePex (VWR
International, Oslo, Norway). The number of immune-
reactive cells was determined by counting positively
stained cells on photomicrographs obtained from three
random high-power microscopic fields (400 magnifica-
tion) under a Leica DM2000 optical microscope, using a
Leica DFC320 digital camera (Leica, Rijswijk, The
Netherlands). Two experienced pathologists (A.R. and
A.C.) with an expertise in vasculitides and with no
access to clinical data evaluated the arteries. The intra-
rater agreement and the inter-rater agreement calculated
by the Cohen’s k coefficient for the two pathologists were
0.81 and 0.72, respectively. In order to study the presence
of atherosclerosis, artery sections were stained with
Masson’s trichrome (Sigma-Aldrich, Sigma, Saint Louis,
Missouri, USA) for cellular components [smooth muscle
cells (SMCs): pink, and red blood cells: red], fibrous
tissue (blue), and fibrin and platelet-rich thrombus
(purple). The study was conducted according to the
Declaration of Helsinki and Italian legislation. Consent
was obtained from all enrolled subjects after the nature
of the investigation was explained and in accordance with
FIG. 1 CD3 immunostaining in histology positive and negative GCA arteries
(AB): representative microphotographs showing hematoxylin and eosin staining (A) and CD3 immunostaining of GCA
artery showing transmural inflammation. (CD): representative microphotographs showing hematoxylin and eosin
staining (C) and CD3 immunostaining in GCA artery without apparent inflammatory infiltrates (D). (EF): representative
microphotographs showing hematoxylin and eosin staining (E) and CD3 immunostaining in control artery (F). G: number
of CD3+ cells in GCA TAB+, GCA TAB and control arteries.
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the approved protocol from the Institutional Review Board
at the University of Palermo and the Arcispedale Santa
Maria Nuova, Reggio Emilia, Italy.
Statistical analysis
Statistical analysis of quantitative variables was performed
using the MannWhitney rank-sum test. P < 0.05 were
considered significant.
Results
One hundred and ten arteries displayed typical histolo-
gical findings of GCA (90 women and 20 men, median
age 77 years, range 6280 years). Eighty patients did not
display any histological feature of GCA but were classified
to be affected by GCA (65 women and 15 men, median
age 77 years, range 5783 years) according to the ACR
classification criteria [6]. Finally, 80 were histologically
normal TAB (62 women, 18 men; median age 68 years,
range 5783 years) from as many patients who did not
fulfil the ACR classification criteria for GCA. In these pa-
tients, the absence of GCA was confirmed by a retro-
spective evaluation of all medical records from
symptoms’ onset to the last visit. We calculated that in
our cohort the sensibility and the specificity of H&E stain-
ing were 57 and 100%, respectively (positive predictive
value 100% and the negative predictive value 50%).
CD3 immunohistochemistry was performed in all the
arteries and the results were considered only in arterial
areas not displaying evidence of atherosclerosis.
According to H&E results, anti-CD3 staining was positive
in all the biopsy-proven GCA patients (Fig. 1A and B;
Table 1). Interestingly, CD3+ staining was also observed
in 60 out of 80 patients with TAB-negative GCA (in the
context of the adventia layer in 54 out of 60 patients and
in the context of media layer in the remaining six) (Fig. 1C
and D; Table 1). Quantitative evaluation of CD3+ cells
demonstrated a significantly higher number of CD3+
cells in TAB-positive and -negative GCA arteries com-
pared with controls (Fig. 1G). No significant differences
were observed regarding ACR criteria between between
biopsy-negative GCA patients with or without T cells in
their biopsies. Among control arteries only 4 out of 80
displayed CD3 positivity (<10 positive cells) (Fig. 1E and
F; Table 1). The addition of CD3 staining to H&E evaluation
modified the sensibility and the specificity of the histologic
examination in 89.47 and 95.00%, respectively. The posi-
tive and negative predictive values were 97.00 and
79.78%.
Discussion
The histologic diagnosis of GCA does not require any
immunohistochemical study of the affected arteries. This
approach might be considered adequate in the presence
of classic transmural inflammation. However, different
subsets of non-classic transmural inflammation have
been described in GCA patients and many other GCA pa-
tients display no histologic inflammation [1]. GCA has long
been considered as a T cell-mediated disease. The mas-
sive infiltration of GCA-positive arteries by activated T ef-
fector cells such as Th1, Th17 and Th9 highlights the
important role of these cells in the pathogenesis of the
disease and makes T lymphocytes an interesting subject
for diagnostic purposes [2, 3]. The presence of CD3+ infil-
trating T cells has been demonstrated in TAB-negative
GCA arteries in a series of studies without, however,
evaluation in a large series of GCA patients [79].
In this study, we demonstrated that CD3+ staining was
present in the majority of arteries obtained from GCA pa-
tients with a negative TAB. Since arteries are immune-
privileged sites, the presence of CD3+ cells in the context
of apparently histologically uninflamed non-atheroscler-
otic GCA arteries may suggest the occurrence of tissue
inflammation. In particular, CD3 immunostaining was
mainly observed in the context of the adventia layer
where vasa vasorum are located. Activation of adventitial
vasa vasorum has been suggested to occur in the early
stage of the disease, leading to the active recruitment
of inflammatory mononuclear cells in the inflamed arteries
[1, 2].
The addition of CD3 immunostaining to the classic
histologic evaluation was accompanied by a significant
increase in the sensibility with a comparable specificity.
Although biopsy-negative GCA characterizes a subset of
patients who often have a different clinical spectrum of the
disease with less severe ischaemic complications than
that of biopsy-proven GCA [10], these results seem to
suggest that CD3 immunostaining should be added to
the routine evaluation of arteries when GCA is strongly
suspected. The main limitation of the present study is
the retrospective design of the study. However, the per-
fect concordance between the presence of CD3+ cells
and the classic histologic signs of GCA and the substan-
tial absence of CD3+ cells in control arteries seem to con-
firm that the presence of abundant CD3+ infiltrating cells
specifically marks inflamed arteries.
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